Stock Market & Financial Investment News

News Breaks January 25, 2013 08:28 EDT REGN, AGN Regeneron compettive concerns overdone, says RW Baird Baird believes Regeneron (REGN) investor concerns regarding Allergan's (AGN) DARPin Phase ll data are overdone as the firm believes approval would be roughly five years out. Baird said the market may be misinterpreting the molecule's half-life and that its potency may be similar at best to Regeneron's Elyea. Shares of Regeneron are Outperform rated with a $205 price target. News For REGN;AGN From The Last 14 Days Check below for free stories on REGN;AGN the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 24, 2013 11:44 EDT REGN Stocks with call strike movement; NFLX REGN Netflix (NFLX) June 255 call option implied volatility increased 1% to 44, Regeneron (REGN) September 300 call option implied volatility decreased 2% to 43 according to IVolatility. May 22, 2013 12:25 EDT REGN Stocks with call strike movement; GME REGN Subscribe for More Information May 20, 2013 19:01 EDT REGN On The Fly: After Hours Movers Subscribe for More Information 17:26 EDT REGN Regeneron, Genentech, Sanofi enter into 'Zaltrap agreement' Subscribe for More Information 17:20 EDT REGN Regeneron,, Bayer, Genentech resolve certain patent disputes Subscribe for More Information 07:28 EDT REGN American Thoracic Society to hold a conference Subscribe for More Information May 17, 2013 10:07 EDT REGN On The Fly: Analyst Initiation Summary Subscribe for More Information 07:16 EDT REGN Regeneron initiated with a Neutral at UBS Subscribe for More Information 06:33 EDT REGN American Thoracic Society to hold a conference Subscribe for More Information May 15, 2013 05:39 EDT REGN Sanofi, Regeneron announce patient enrollment in two Phase 3 trials Subscribe for More Information May 14, 2013 07:34 EDT REGN Regeneron outlook positive, says RBC Capital Subscribe for More Information 07:18 EDT AGN BofA/Merrill to host a conference 2013 Health Care Conference is being held in Las Vegas on May 14-16. Sign up for a free trial to see the rest of the stories you've been missing.